Key result
Propranolol did not alter vigilance, performance, or subjective assessment compared to placebo in healthy volunteers, though reaction time improved in failure-motivated subjects.
Why the study?
Does propranolol alter psychophysical performance in healthy volunteers?
RCT (n=8)
Double-blind
Does propranolol alter psychophysical performance in healthy volunteers?
Propranolol does not significantly alter overall psychophysical performance in healthy volunteers, though it may have differential effects based on baseline motivation.
Answers are grounded in this paper and cite their sources.
Propranolol need not raise performance concerns in healthy adults; confirms neutral cognitive effects of acute beta-blockade outside clinical populations.
Eight volunteers out of 81 medical students of a one‐year register were selected in a two‐step procedure by means of a motivation Q‐sort. Of these, four were motivated for success (S.M.), whereas four were motivated for failure (F.M.). Following a stratification step, two subjects each from each group were orally given propranolol (0.6 mg/kg) or placebo in a double‐blind trial. Test inventory; flicker fusion frequency; determination performance in normal and tailored testing; subjective self‐rating; blood pressure; pulse. Evaluation was accomplished in the conventional dose‐related way (propranolol versus placebo) and in a serum level oriented approach common in differential psychopharmacology, by judging the personality structure (nervousness, neuroticism, extraversion) and the volunteers' motivation. It was found that propranolol when compared to placebo did not alter the vigilance, performance and subjective assessment of the volunteers; hence, the next step of evaluation was made regardless of the treatment. The initial performance of F.M. subjects as measured on the determination test unit was substantially poorer when compared to S.M. volunteers. During a 7.5‐h period after application, the reaction time of F.M. subjects was noted to improve both as a result of training due to repeated tests and as a function of propranolol. As only a small number of volunteers was available for the investigation, further studies are encouraged to verify performance of F.M. subjects.
No takes yet. Share an insight, caveat, or question.
Meyer et al. (1993) conducted an RCT in Healthy volunteers (n=8). Propranolol vs. Placebo was evaluated on Vigilance, performance, and subjective assessment. Propranolol did not alter vigilance, performance, or subjective assessment compared to placebo in healthy volunteers, though reaction time improved in failure-motivated subjects.
Synapse has enriched 10 related papers. Consider them for comparative context: